Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study

The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.

Aug 1, 2024 - 21:00

0 5

Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study

The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.

Tags:

Previous Article

Shell beats second-quarter profit expectations, launches $3.5 billion share buyb...

Your health records are coming to new apps. Here's why

admin

admin

This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.